Weekly paclitaxel in the management of ovarian cancer

被引：0
作者：
Markman, M
机构：
[1] Cleveland Clin Fdn, Dept Med Hematol Oncol, Cleveland, OH 44195 USA
[2] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 40
页数：4
相关论文
共 31 条
[1]  
ABURUSTUM NR, 1997, P AN M AM SOC CLIN, V16, pA364
[2]  
AGHAJANIAN C, 1996, P AN M AM SOC CLIN, V15, P286
[3]   Taxol given weekly in advanced previously treated ovarian carcinomas - a pilot study [J].
Andersson, H ;
Horvath, G ;
Mellqvist, L ;
Westberg, R .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (04) :262-266
[4]  
BREMER K, 1999, P AM SOC CLIN ONCOL, V18, pA367
[5]   Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: Unexpected incidence of neurotoxicity [J].
Connelly, E ;
Markman, M ;
Kennedy, A ;
Webster, K ;
Kulp, B ;
Peterson, G ;
Belinson, J .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :166-168
[6]   Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer [J].
duBois, A ;
Luck, HJ ;
Bauknecht, T ;
Mobus, V ;
Bochtler, H ;
Diergarten, K ;
Meerpohl, HG .
ANNALS OF ONCOLOGY, 1997, 8 (04) :355-361
[7]  
DUBOIS A, 1999, P AN M AM SOC CLIN, V18, pA356
[8]   PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA [J].
EINZIG, AI ;
WIERNIK, PH ;
SASLOFF, J ;
RUNOWICZ, CD ;
GOLDBERG, GL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1748-1753
[9]   EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION [J].
EISENHAUER, EA ;
HUININK, WWT ;
SWENERTON, KD ;
GIANNI, L ;
MYLES, J ;
VANDERBURG, MEL ;
KERR, I ;
VERMORKEN, JB ;
BUSER, K ;
COLOMBO, N ;
BACON, M ;
SANTABARBARA, P ;
ONETTO, N ;
WINOGRAD, B ;
CANETTA, R .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2654-2666
[10]   Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer [J].
Fennelly, D ;
Aghajanian, C ;
Shapiro, F ;
OFlaherty, C ;
McKenzie, M ;
OConnor, C ;
Tong, W ;
Norton, L ;
Spriggs, D .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :187-192
1234